Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A high grade glioma that is characterized by the absence of histone H3, IDH1, and IDH2 mutations.
Biomarker and diagnostic research for diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
11 publications have been identified in PubMed for diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype. Research spans Review / Meta-Analysis (36%), Basic Science / Preclinical (27%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 4 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:42 AM UTC
Laboratory research | 3 | 27% |
Testing and diagnosis research | 2 | 18% |
Patient case studies | 1 | 9% |
Disease patterns and progression | 1 | 9% |
Cheaney B 2nd (2026). [PMID: 41878701](https://pubmed.ncbi.nlm.nih.gov/41878701/). *Neurooncol Adv*. [Basic Science / Preclinical]
Santosh V (2026). [PMID: 41139930](https://pubmed.ncbi.nlm.nih.gov/41139930/). *Brain Pathol*. [Review / Meta-Analysis]
Bhardwaj S (2026). [PMID: 41798129](https://pubmed.ncbi.nlm.nih.gov/41798129/). *Neurooncol Pract*. [Diagnostic / Biomarker]
Zeng Y (2026). [PMID: 42126442](https://pubmed.ncbi.nlm.nih.gov/42126442/). *Childs Nerv Syst*. [Review / Meta-Analysis]
Wesseling P (2026). [PMID: 40887057](https://pubmed.ncbi.nlm.nih.gov/40887057/). *Brain Pathol*. [Diagnostic / Biomarker]
Balaguer-Lluna L (2025). [PMID: 39961939](https://pubmed.ncbi.nlm.nih.gov/39961939/). *J Neurooncol*. [Basic Science / Preclinical]
Kim JW (2025). [PMID: 40980447](https://pubmed.ncbi.nlm.nih.gov/40980447/). *Neurooncol Adv*. [Epidemiology / Natural History]
Kurokawa R (2025). [PMID: 40853542](https://pubmed.ncbi.nlm.nih.gov/40853542/). *Radiol Med*. [Review / Meta-Analysis]
Gilani A (2025). [PMID: 39655782](https://pubmed.ncbi.nlm.nih.gov/39655782/). *Pediatr Dev Pathol*. [Case Report / Case Series]
Yoel A (2024). [PMID: 39273062](https://pubmed.ncbi.nlm.nih.gov/39273062/). *Cells*. [Review / Meta-Analysis]